AOD-9604 may theoretically interact with beta-blockers by antagonising beta-3 receptor signalling, though this hasnt been clinically documented
Yamamoto Y, Aizawa K, Mieno M, et al
[PubMed] [Google Scholar] 59.Stupnisek M, Franjic S, Drmic D, Hrelec M, Kolenc D, Radic B, Bojic D, Vcev A, Seiwerth S, Sikiric P
Strinic D, Belosic Halle Z, Luetic K, Nedic A, Petrovic I, Sucic M, Zivanovic Posilovic G, Balenovic D, Strbe S, Udovicic M, Drmic D, Stupnisek M, Lovric Bencic M, Seiwerth S, Sikiric P
Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-mediated ca 2+ Fluxes and prolactin release in GH3/B6 pituitary tumor cells
Human or veterinary use is strictly prohibited